Research peptide
ARA-290
10 mg
Select size
$59.00CAD
Volume pricing
- Buy 2Save 5%$112.10 ($56.05 each)
- Buy 3Save 10%$159.30 ($53.10 each)
Applies to the total quantity in your cart.
Research material
Supplied in a sealed glass vial and labelled with a batch reference. Batch-specific documentation is available on request. For Research Use Only. Not for Human or Animal Use.
- Presentation
- 10 mg
- Container
- Sealed glass vial
- Batch reference
- Printed on every unit
- Documentation
- Batch-specific COA on request
- Research use
- For Research Use Only
Description
ARA-290 (Cibinetide) is an investigational 11-amino-acid peptide derived from erythropoietin (EPO) and engineered to investigate the tissue-protective and neuroprotective pathways associated with EPO signalling. Unlike native erythropoietin, ARA-290 is designed to target the Innate Repair Receptor (IRR) without stimulating erythropoiesis or increasing red blood cell production.
Clinical research has investigated ARA-290 across multiple areas, including neuropathic conditions, inflammation, tissue repair and vascular biology. Research interest has particularly focused on its potential influence on nerve repair, neuroprotection, wound healing, inflammatory signalling and tissue recovery.
With multiple clinical studies having explored cibinetide, ARA-290 remains an area of interest for researchers investigating endogenous repair mechanisms, neuroprotective signalling and tissue-regeneration pathways.
Kinetus Biolabs | Precision Science. Peak Potential.
Research Use Only — Not for Human Consumption.
